Assia Ghaouti-Lamrani

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.

5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.

Journal: Lancet (London, England)

Published: October 06, 2025

The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France.

The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 27, 2025

Enhancing Expertise in Reirradiation: Results from a Training Workshop Organized by Unicancer, the Federation of French Cancer Centers.

Enhancing Expertise in Reirradiation: Results from a Training Workshop Organized by Unicancer, the Federation of French Cancer Centers.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: March 14, 2025

Early Breast Cancer Treatment and Cardiac Events: A Systematic Review.

Early Breast Cancer Treatment and Cardiac Events: A Systematic Review.

Journal: Clinical breast cancer

Published: October 29, 2024

Prediction of the need of enteral nutrition during radiation therapy for head and neck cancers.

Prediction of the need of enteral nutrition during radiation therapy for head and neck cancers.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 24, 2024

Clinical research in private sector: Which strategic analysis?

Clinical research in private sector: Which strategic analysis?

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 18, 2023

Real world data in radiotherapy: A data farming project by Unitrad

Real world data in radiotherapy: A data farming project by Unitrad

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 08, 2023

Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.

Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.

Journal: The Lancet. Oncology

Published: March 03, 2023

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.

Journal: BMC cancer

Published: February 20, 2023

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.

Journal: Cancer immunology, immunotherapy : CII

Published: October 23, 2022

Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.

Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 29, 2022

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.

Journal: BMC cancer

Published: May 22, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026